earnings
confidence high
sentiment negative
materiality 0.80
Stryker Q2 organic sales +6.1% to $4.5B; lowers FY adjusted EPS guidance to $9.30-$9.50
STRYKER CORP
2022-Q2 EPS reported
$2.56
revenue$8,768,000,000
- Reported net sales of $4.5B (+4.6% YoY); organic net sales +6.1%.
- Reported EPS $1.72 (+11%); adjusted EPS of $2.25 flat YoY.
- MedSurg & Neurotechnology organic sales +7.9%; Orthopaedics & Spine organic +3.9%.
- Adjusted operating margin contracted 220 bps to 23.7%; FY22 organic sales guidance raised to 8-9%.